Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
226 articles on this topic
-

Kisspeptin and Testosterone: Pattern Beats Amount
A study published on August 3, 2026 gave 15 healthy men kisspeptin-10 three different ways. Five days of it around the clock and the pituitary stopped answering; eight hours on and sixteen off, and it kept answering for twelve days.
-

Mounjaro vs Zepbound: Same Drug, Two Labels
Both pens hold tirzepatide and run the same dose ladder. What differs is the use printed on the carton — and that is what your insurer reads.
-

Semaglutide for Children: What STEP Young Means
Semaglutide for children ages 6 to 11 has encouraging new trial results, but the news has not changed who can receive Wegovy under its current label. The evidence is promising, early, and best read with a pediatrician.
-

Sermorelin Nasal Spray: What Gets Past Your Nose
The one study that measured it found about 3 to 5 percent of a nasal dose reached the bloodstream. That number, and what happened when researchers kept spraying for six months, is most of the story.
-

What Is Semaglutide Used For? A Plain Guide
Semaglutide has different jobs depending on the brand: blood sugar control, heart or kidney risk reduction, long-term weight management, or certain liver disease. Here is the plain list before a first visit.
-

What Is Tesamorelin Used For?
Tesamorelin has one narrow labeled use: reducing excess abdominal fat in adults with HIV-associated lipodystrophy. Uses beyond that label need a more careful answer.
-

503A Bulks List: What It Means
The 503A bulks list is a narrow ingredient pathway for patient-specific compounding. Here is how it differs from FDA categories, drug review and the separate 503B list.
-

Is BPC-157 FDA Approved? No—The Vote Was Advisory
BPC-157 is not FDA-approved, and no approved BPC-157 product exists anywhere. The July 2026 vote was advice on compounding, not drug approval.
-

Paradigm Peptides: A Lab Certificate Is Not Proof
The Paradigm Peptides sentencing exposed a simple weakness in buying medicine from an unlicensed website: a polished lab certificate can be fake. The safer difference is an accountable chain—a prescriber, a named pharmacy and records regulators can inspect.
-

Best Tirzepatide Compounding Pharmacy Checklist
The best choice is a pharmacy you can verify: licensed, tied to a real prescription, clear about sterile preparation, and accountable for the vial after it leaves the building.
-

How to Report Peptide Side Effects So It Counts
An NBC News investigation in August found that problems linked to peptides often go nowhere at all. Here is where a report actually lands, and in what order to make it.
-

Kisspeptin Benefits: What Human Studies Found
In people, kisspeptin has done two things reliably: switched on the reproductive hormone system, and changed how the brain handles sexual cues. Nearly all of it was measured over hours, in a hospital.
-

Sermorelin Cost: What You’re Really Paying For
In three current public telehealth listings, recurring sermorelin plans run from $149 to $279 a month. The useful comparison is not just the vial price, but what the plan includes and who is accountable for it.
-

Tesamorelin Half-Life Is Measured in Minutes
Tesamorelin leaves the bloodstream quickly, but the signal it starts can last much longer. That difference explains why trials used it once daily and why providers follow IGF-1 instead of watching the clock.
-

Tirzepatide Pills Don't Exist. Here's What Does
There is no oral tirzepatide, either as a brand product or a validated compounded pill. Real GLP-1 tablets contain semaglutide or orforglipron, which are different medicines.
-

Zepbound vs Wegovy: Two Drugs, Not Two Brands
They get compared like two versions of one medicine. They are not — different molecules, different makers, and different lists of what each one is cleared to treat.
-

No Shortcut: The Peptide FDA Approval Process
Mimrylo’s August 2026 approval is a useful look at the whole path: permission to begin human studies, three trial phases, a full application, manufacturing review, and a label limited to one use.
-

Is Sermorelin FDA Approved? Not Since 2009
Geref, the only sermorelin product the United States ever approved, left the market in 2008 and its approvals were withdrawn in 2009 — not over safety. Here is what that means for a prescription today.
-

Kisspeptin for Men: What the Studies Really Show
Kisspeptin may affect reproductive hormones and sexual response in men. The evidence is promising but small, and it does not establish a standard dose or long-term treatment plan.
-

Tirzepatide Heart Benefits: Who the Label Covers
In August 2026 the brand-name version of tirzepatide gained a new use on its label: lowering the risk of heart attack, stroke and cardiac death in adults with type 2 diabetes. Here is what that covers, and what it doesn't.
Page 6 of 12 · 226 articles